Search Within

Genitourinary Oncology Service

  1. "Bernard Bochner"
Formats
  1. Meeting Abstract (107)
  2. Journal Article (71)
  3. Correspondence (6)
  4. Guidelines (2)
  5. Review (2)
  6. Editorial (1)
  7. Research Letter (1)
Groups
  1. Department of Medicine (190)
  2. Solid Tumor Oncology Division (190)
  3. Surgery (190)
  4. Urology (190)
  5. Department of Pathology and Laboratory Medicine (136)
  6. Human Oncology and Pathogenesis Program (126)

More Groups

People
  1. Bernard Bochner (190)
  2. Dean Bajorin (141)
  3. Gopakumar Iyer (131)
  4. Hikmat Al-Ahmadie (131)
  5. Jonathan Rosenberg (125)
  6. David Solit (122)

More People

Years
  1. 2025 (6)
  2. 2024 (10)
  3. 2023 (16)
  4. 2022 (15)
  5. 2021 (15)
  6. 2020 (14)

More Years

Publications
  1. Journal of Clinical Oncology (59)
  2. Laboratory Investigation (18)
  3. Modern Pathology (17)
  4. Journal of Urology (11)
  5. Urologic Oncology: Seminars and Original Investigations (11)
  6. Clinical Cancer Research (9)

More Publications

Publishers
  1. American Society of Clinical Oncology (63)
  2. Nature Publishing Group (25)
  3. Elsevier Science, Inc. (22)
  4. Elsevier Inc. (21)
  5. American Association for Cancer Research (18)
  6. Nature Research (17)

More Publishers

Results (190)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Re-analysis of intravesical gemcitabine in the era of Bacillus Calmette-Guérin (BCG)-unresponsive non–muscle-invasive bladder cancer
    Journal Article

    De Jesus Escano, M. R.; Vertosick, E. A.; D'Souza, N.; Benfante, N.; Lenis, A. T.; Reisz, P. A.; Gaffney, C.; Goh, A.; Donahue, T. F.; Cha, E.; more...
    Urologic Oncology: Seminars and Original Investigations (2025)

    Fulltext@MSK | Save
  • Clinical outcomes, genomic heterogeneity, and therapeutic considerations across histologic subtypes of urothelial carcinoma
    Journal Article

    Chu, C. E.; Chen, Z.; Whiting, K.; Ostrovnaya, I.; Lenis, A. T.; Clinton, T. N.; Rammal, R.; Ozcan, G. G.; Akbulut, D.; Basar, M.; more...
    European Urology (2025)

    Fulltext@MSK | Save
  • Comprehensive molecular, pathological, and clinical characterization of clear cell adenocarcinoma of the urinary tract
    Journal Article

    Rammal, R.; Koll, F. J.; Chen, Z.; Tallman, J. E.; Alam, S. M.; Eichholz, J. E.; Chatila, W.; Agbamu, T.; Lenis, A. T.; Basar, M.; more...
    Modern Pathology (2025)

    Fulltext@MSK | Save
  • Updated long-term follow-up from a phase II clinical trial of gemcitabine and cisplatin as neoadjuvant chemotherapy for patients with high-grade upper tract urothelial carcinoma
    Meeting Abstract

    Jayalath, V.; Teo, M. Y.; Assel, M.; Rodriguez, D.; Meyerson, A.; Bochner, B. H.; Dalbagni, G.; Donat, S. M.; Herr, H. W.; Cha, E. K.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Correlative science from a phase I study of intravesical Fc-optimized anti-CD40 agonist antibody 2141-V11 for non-muscle invasive bladder cancer (NMIBC) unresponsive to bacillus calmette-guerin (BCG)
    Meeting Abstract

    Bochner, B. H.; Alam, S. M.; Blanchard, L.; Yao, N.; Angulo-Lozano, J.; Wong, J.; Knorr, D.; Whiting, K.; Seshan, V.; Donahue, T.; more...
    Urologic Oncology: Seminars and Original Investigations (2025)

    Fulltext@MSK | Save
  • Transcriptional analysis of bladder cancer histologic subtypes reveals novel drug target heterogeneity
    Meeting Abstract

    Tallman, J. E.; Kuo, F.; Koll, F.; Alam, S. M.; Basar, M.; Luo, J.; Gao, S. P.; Tang, X.; Yol, C.; Gokturk, G.; more...
    Urologic Oncology: Seminars and Original Investigations (2025)

    Fulltext@MSK | Save
  • Molecular, immunohistochemical and clinical determinants of urothelial carcinoma of the bladder with nested subtype
    Meeting Abstract

    Koll, F. J.; Basar, M.; Chen, Z.; Tin, A. L.; Alam, S. M.; Tallman, J. E.; Clinton, T. N.; Whiting, K.; Chen, J. F.; Sarungbam, J.; more...
    European Urology (2024)

    Fulltext@MSK | Save
  • Differential NEUROD1, ASCL1, and POU2F3 expression defines molecular subsets of bladder small cell/neuroendocrine carcinoma with prognostic implications
    Journal Article

    Akbulut, D.; Whiting, K.; Teo, M. Y.; Tallman, J. E.; Ozcan, G. G.; Basar, M.; Jia, L.; Rammal, R.; Chen, J. F.; Sarungbam, J.; more...
    Modern Pathology (2024)

    Fulltext@MSK | Save
  • Natural history and genomic landscape of chemotherapy-resistant muscle-invasive bladder cancer
    Journal Article

    Lenis, A. T.; Whiting, K.; Ravichandran, V.; Tallman, J. E.; Alam, S. M.; Chu, C. E.; De Jesus Escano, M.; Bochner, E.; Katims, A.; Reisz, P. A.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • ERBB2 alterations in non-muscle invasive bladder cancer are associated with a distinct genomic signature
    Meeting Abstract

    Alam, S. M.; Tallman, J.; Koll, F.; D'Souza, N.; de Jesus Escano, M.; Donahue, T.; Goh, A.; Sarungbam, J.; Berger, M.; Schultz, N.; more...
    Urologic Oncology: Seminars and Original Investigations (2024)

    Fulltext@MSK | Save